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ABSTRACT 
Two simple, accurate, precise and cost effective UV-Spectrophotometric methods have been developed for estimation of Atazanavir sulphate (ATV), 
an anti-HIV drug, in bulk and pharmaceutical dosage form. Method A is Absorbance maxima method, which is based on measurement of absorption 
at maximum wavelength, 247nm. Method B is Area under Curve (AUC), in wavelength range of 240-254nm. The linear responses were observed in 
the range of 5- 40 μg/ml for both the methods, with the regression coefficient of 0.9996 and 0.9997 respectively. The accuracy of the methods was 
assessed by recovery studies and was found to be 100.56% and 100.86% respectively. The developed methods were validated for different 
parameters like linearity, accuracy (recovery), precision and specificity, as per the ICH Q2 R1 (International Conference for Harmonization) 
guidelines and were found to be satisfactory. These methods can be used for the determination of Atazanavir sulphate in bulk and formulation 
without interference of the excipients. 
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INTRODUCTION 
Atazanavir sulphate (ATV) is a chemically (3S,8S,9S,12S)-3,12-
Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-
{[4-(2-pyridinyl)phenyl]methyl}-2,5,6,10,13 penta aza tetra decane 
dioic acid dimethyl ester, sulphate(1:1) (figure1). ATV is an 
antiretroviral agent for the treatment of HIV infection and 
consequently it is clinically useful in the treatment of AIDS. 
Atazanavir sulfate, azapeptide inhibitor of HIV-1 protease, is 
indicated in combination with other antiretroviral agents for the 
treatment of HIV-1 infection. Atazanavir sulfate is a white to pale 
yellow powder. It is slightly soluble in water. [2] The drug was 
approved by the United States Food and Drug Administration 
(USFDA) in June2003. Structure–activity studies with a series of 
azadipeptides designed to mimic the transition state of the peptide-
cleavage reaction catalyzed by HIV-1 protease identified lead 
compounds that had either potent antiviral activity against mutant 
HIV-1 strains or good oral bioavailability, but not both. Atazanavir is 
given with food by mouth as the sulfate and the usual adult dose is 
400 mg once daily. The drug is well absorbed when administered 
orally with food (bioavailability 68%). The drug is highly bound to 
plasma proteins (86%) and is metabolized by CYP3A isozyme. It is a 
moderate inhibitor of CYP3A.Literature survey revealed few RP-HPLC 
and spectrophotometric methods for estimation of Atazanavir.
The objective of the present work is to develop simple 
spectrophotometric methods for estimation of Atazanavir sulfate in 
bulk and formulation with good accuracy, simplicity, precision and 
economy over other chromatographic methods and which can be 
used for routine analysis.  
















Fig. 1: Structure of ATV 
MATERIALS AND METHODS 
Chemicals 
Pure sample of ATV was received as a gift sample from Ranbaxy lab. 
The percentage purity of ATV was 99.85% w/w. Formulation 
containing ATV sulphate 300mg (Atazor Capsule 300mg, Cipla 
Pharmaceuticals, Hinjewadi, Pune) was used for the analysis. 
Spectroscopy grade methanol (Thomas Baker) and Distilled water 
were used. For the studies. 
Instrumentation 
A Jasco double beam UV–visible spectrophotometer, Model: V-630, 
with a fixed bandwidth (2nm) and 1-cm quartz cell was used for 
Spectral and absorbance measurements. In addition, electronic 
balance, micropipette and sonicator were used in this study. 
 
Fig. 2: Spectra of ATV (Conc.10ug/ml) 
 
Preparation of stock solution 
Accurately weighed about 100 mg of pure drug and dissolved in 
50% methanol and final volume made up to 100 ml with distilled 
water to give standard stock solution (1000 ug/ml). Aliquots of 
standard stock solution were pipette out and suitably diluted with 
distilled water to get the final concentration of 5-40 ug/ml of 
standard solution for both the method. The solutions were scanned 
in the spectrum mode from 400 nm to 200 nm wavelength range 
and the maximum absorbance shown at 247 nm (figure 2) for 
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Method A and similarly for Method B AUC shown in the range of 
240-254 nm (Figure 4). 
Selection of wavelength 
Standard stock solution of 1000 ug/ml was prepared in methanol 
(50%) and further aliquots were made using distilled water. The 
standard solution of concentration 10 ug/ml was prepared in 
distilled water and scanned between 200-400 nm and λmax was 
found to be at 247 nm for Method A and similarly for Method B AUC 
shown in the range of 240-254 nm (Figure 4). 
 
Fig. 3: Absorbance maxima method for ATV (Conc. 5-40ug/ml) 
 
 
Fig. 4: Area under Curve of ATV 
 
Method A: Absorbance Maxima Method  
Aliquots of standard stock solution of concentration 1000 μg/ml 
were taken and suitably diluted with distilled water to get working 
standard solutions in the increasing concentration range (5-
40ug/ml). These were scanned in the range of 200-400 nm. The 
absorbance maximum was found to be at 247nm. The calibration 
curve was plotted with concentration v/s absorbance and regression 
equation was calculated and it was found to be 0.9996 (Figure 5). 
Method B: Area under Curve Method 
From the spectra of drug obtained after scanning of standard 
solution of ATV, area under the curve in the range of 240-254nm 
was selected for the analysis (Figure 4). The calibration curve was 
prepared in the concentration range of 5-40 µg/ml at their 
respective AUC range and regression equation was calculated and it 
was found to be 0.9997 (Figure 6). 
The drug followed the Beer-Lambert’s law in the concentration 
range of 5-40 μg/ml for the both methods. For the both methods 
(Absorption maxima and Area under Curve) the coefficient of 
correlation (r), slope (m) and intercept (c) values of this method are 
given in Table 2. 
Analysis of marketed formulation 
Twenty capsules (Atazor 300mg, Cipla Pharmaceuticals., Hinjewadi, 
Pune) were weighed accurately and tablet weight equivalent to 300 
mg of ATV was weighed accurately and transferred to 100 ml of 
mixture of Methanol and Distilled Water (50:50% v/v) to get 
standard stock solution of 3000 µg/ml and sonicated for 5min. The 
solution was filtered through filter paper no. 41; 10 ml of this filtrate 
was further diluted to 100 ml of distilled water. From this solution, 
further dilutions of ATV were made in the calibration range using 
distilled water. The solution was scanned in the range of 200-400 
nm against blank and maximum absorbance was recorded at 
wavelength 247 nm for Method A and similarly for Method B AUC 
was measured in between 240-254 nm. 
Validation of uv method 
Validation of the UV method was done with respect to following 
parameters. 
Linearity and Range  
The standard solutions were prepared by dilution of the stock 
solution with to reach a concentration range equivalent mixture 
Methanol and Distilled water. The Absorbance was plotted against 
the corresponding concentrations to obtain the calibration curves 
(Figure 5) and (Figure 6) for both the methods.  
Accuracy 
Recovery studies was carried out by applying the method to drug 
sample to which known amount of ATV corresponding to 80, 100, 
120% of label claim has been added (standard addition method).  
Precision 
Precision of the method was verified by repeatability and 
intermediate precision studies. Repeatability studies (intra-day) 
were performed by analysis of ATV respectively on the same day. 
Intermediate precision (inter-day) of the method was checked by 
repeating analysis of ATV on a different day. Measurement of peak 
area for active compound was expressed in terms of % relative 
standard deviation (%R.S.D.) for both the methods 
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Fig. 5: Linearity of ATV (API), by Method A 
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Fig. 6: Linearity of ATV (API), by Method B
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Table 2: Table shows Optical characteristics and precision 
S. No. Parameter Method A Method B 
1 λ max/wavelength range(nm) 247 240-254 
2 Beer’s law limit (μg/ml) 5-40 5-40 
3 Molar absorptivity (L/mol/cm) 18060.47 241787.37 
4 Sandell’s sensitivity (μg/Sq.cm/0.001) 0.044458 0.03321 
5 Correlation coefficient (r ) 0.9996 0.9997 
6 Slope (m) 0.0225 0.3011 
7 Intercept 0.0125 0.1762 
 
Table 3: Table shows Results of Analysis of Tablet Formulation (N* 
Method 
=6) 
Label claim mg Amount of drug estimated (mg/tab) %Label claim* 
± SD 
Method A 300 100.56 100.56±0.001 
Method B 300 100.86 100.86±0.018 
 
Table 4: Table shows Result of Recovery studies 







Method A Method B Method A Method B Method A Method B 
80 99.90 100.22 0.1578 0.1747 0.00106 0.01441 
100 100.16 100.51 0.2014 0.1875 0.001306 0.01665 
120 100.15 100.13 0.1995 0.2699 0.00040 0.03335 
RSD: Relative Standard deviation b) SE: Standard error  
 
Table 5: Table shows result of intra-day and inter-day precision 
S. No. Intra-day precision Inter-day precision 
SE SD %RSD SE SD %RSD 
Method A 0.00220 0.002018 0.5735 0.000486 0.000591 0.1774 
Method B 0.01792 0.01856 0.3913 0.006533 0.007949 0.1778 
 
RESULT AND DISCUSSION  
The methods discussed in the present work provide a convenient 
and accurate way for analysis of ATV in its pharmaceutical dosage 
form. Absorbance maxima of ATV at 247 nm (Method A); Area under 
Curve of ATV at 240-254 nm (Method B) were selected for the 
analysis. Linearity for detector response was observed in the 
concentration range of 5-40 μg/ml for the two methods. Percent 
label claim for ATV in capsule analysis was found in the range of 
100.56% to 100.86% (Table 3).  
Standard deviation and coefficient of variance for six determinations 
of capsule formulation, was found to be less than ± 2.0 indicating the 
precision of the methods. Accuracy of proposed methods was 
ascertained by recovery studies and the results are expressed as % 
recovery.  
Percent recovery for ATV was found in the range of 99.90 % to 
100.51 % values of standard deviation and coefficient of variation was 
satisfactorily low indicating the accuracy of all the methods (Table 4). 
Percent RSD for Intra-day assay precision was found to be 0.5735 and 
0.3913 for Method A and B (Table 5).  
Inter-day assay precision was found to be 0.1774 and 0.1778 for Method 
A and B (Table 5). Based on the results obtained, it is found that the 
proposed methods are accurate, precise, reproducible & economical 
and can be employed for routine quality control of ATV in bulk drug 
and its pharmaceutical dosage form.  
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